Financhill
Back

Reneo Pharmaceuticals Quote, Financials, Valuation and Earnings

Reneo Pharmaceuticals Price Quote

$1.81
-0.01 (4.02%)
(Updated: October 5, 2024 at 6:49 AM ET)

Reneo Pharmaceuticals Key Stats

Sell
41
Reneo Pharmaceuticals (RPHM) is a Sell

Day range:
$1.68 - $1.90
52-week range:
$0.98 - $9.21
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.79%

Volume:
423.6K
Avg. volume:
252.2K
1-year change:
-75.24%
Market cap:
$60.8M
Revenue:
$0
EPS:
$-1.69

How Much Does Reneo Pharmaceuticals Make?

Data Unavailable

Is Reneo Pharmaceuticals Growing As A Company?

Data Unavailable

Reneo Pharmaceuticals Stock Price Performance

What Is Reneo Pharmaceuticals 52-Week High & Low?

Reneo Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Reneo Pharmaceuticals?

Is Reneo Pharmaceuticals Cash Flow Positive?

  • What Is RPHM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$66.3M
  • What Is Reneo Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$4M
  • What Is Reneo Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $97.3M

Reneo Pharmaceuticals Return On Invested Capital

Data Unavailable

Reneo Pharmaceuticals Earnings Date & Stock Price

Reneo Pharmaceuticals Competitors

Reneo Pharmaceuticals Dividend Yield

Reneo Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -60%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 1.50
Downside from Last Price: -17.58%

Major Shareholders

  • How many RPHM shares are owned by institutional investors?
    32.3M RPHM shares are owned by institutional investors
  • How many RPHM shares are owned by insiders?
    1.3M RPHM shares are owned by insiders